Description
A highly potent, selective, long-acting, and orally bioavailable DPP-4 inhibitor with IC50 of 1nM; no significant inhibition on hERG and muscarinic receptor M1 at 1uM; shows considerable blood glucose lowering in different animal species. Diabetes Approved